MetLife Investment Advisors »

Tg Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 72k 17.08
2023-09-30 $605k 72k 8.36
2023-06-30 $1.8M 72k 24.84
2023-03-31 $1.1M 70k 15.04
2022-12-31 $829k 70k 11.83
2022-09-30 $415k 70k 5.92
2022-06-30 $272k 64k 4.25
2022-03-31 $678k 71k 9.51
2021-12-31 $852k 45k 19.00
2021-09-30 $1.5M 45k 33.28
2021-06-30 $1.7M 45k 38.79
2021-03-31 $2.2M 45k 48.20
2020-12-31 $2.4M 47k 52.02
2020-09-30 $1.3M 47k 26.76
2020-06-30 $839k 43k 19.49
2020-03-31 $371k 38k 9.84
2019-12-31 $419k 38k 11.10
2019-09-30 $212k 38k 5.62
2019-06-30 $245k 28k 8.66
2019-03-31 $227k 28k 8.04
2018-12-31 $116k 28k 4.10
2018-09-30 $246k 44k 5.61
2018-06-30 $372k 28k 13.15
2018-03-31 $297k 21k 14.19
2017-12-31 $172k 21k 8.22